As aquaculture embraces advanced vaccination technologies, its potential to mitigate antimicrobial resistance emerges, bridging two critical health domains. Fish vaccines are increasingly vital in the fight against disease in aquaculture, projected to exceed $600 million globally by 2030. Concurrently, the vaginal microbiome’s role in antibiotic resistance underscores the importance of innovative approaches in managing microbial health, potentially influencing vaccine development. This intersection reveals how advancements in aquaculture vaccination can inform broader strategies against antimicrobial resistance, ensuring sustainable and healthy food systems.
